Skip to main content

Want a detailed portfolio tracker?

XBiotech (XBIT) P/E (2015 - 2026)

XBiotech (XBIT) P/E from Apr 15, 2015 to Jul 21, 2026. The TTM XBiotech (XBIT) P/E is -1.70. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of XBiotech (XBIT)

YearP/EChange
2026-1.70+6.28%
2025-1.60-48.78%
2024-3.12-40.68%
2023-5.27+78.22%
2022-2.95-84.71%
2021-19.32-2093.66%
20200.97-16.51%
20191.16-113.20%
2018-8.79-73.10%
2017-32.69+381.51%
2016-6.79-24.67%
2015-9.01N/A

Comparison XBiotech (XBIT) P/E with competitors

XBiotech (XBIT) P/E is -1.70.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.10%
NBYStablecoin Development Corp0.00-100.25%
ENLVEnlivex Ltd0.07-104.40%
FGENFibroGen Inc0.24-114.12%
CHRSCoherus Biosciences Inc0.85-149.90%
FBIOFortress Biotech Inc0.95-155.81%
ORMPOramed Pharmaceuticals Inc1.50-188.39%
AGENAgenus Inc3.01-276.98%
INVAInnoviva Inc3.15-285.47%
VXRTVaxart Inc3.55-308.74%
CRMDCorMedix Inc3.63-313.37%
CVACCureVac N.V.4.45-361.42%
GLPGGalapagos NV4.86-385.72%
SRPTSarepta Therapeutics Inc4.88-387.08%
ABEOAbeona Therapeutics Inc5.39-416.80%
ABUSArbutus Biopharma Corp5.60-429.04%
ZVRAZevra Therapeutics Inc5.89-446.19%
SPROSpero Therapeutics Inc6.23-466.25%
CGENCompugen Ltd6.31-471.28%
RIGLRigel Pharmaceuticals6.87-504.10%
SLXNSilexion Therapeutics Corp7.30-529.04%
OMEROmeros Corporation9.26-644.45%
AUPHAurinia Pharmaceuticals Inc9.58-663.63%
PLXProtalix BioTherapeutics Inc10.89-740.43%
ACADAcadia Pharmaceuticals Inc11.73-789.68%
TBPHTheravance Biopharma Inc12.26-821.06%
ADMAAdma Biologics Inc12.42-830.23%
HRMYHarmony Biosciences Holdings Inc13.82-912.68%
SABSSAB Biotherapeutics Inc14.14-931.26%
NAGENiagen Bioscience Inc14.82-971.36%
INCYIncyte Corp15.82-1030.43%
REGNRegeneron Pharmaceuticals Inc15.86-1032.43%
PBYIPuma Biotechnology Inc17.32-1118.23%
CPRXCatalyst Pharmaceuticals Inc17.44-1125.50%
EXELExelixis Inc17.54-1131.30%
TGTXTG Therapeutics Inc18.97-1215.28%
MDXGMimedx Group Inc20.55-1308.57%
XOMAXOMA Royalty Corp22.87-1445.15%
ARGXArgen X SE24.30-1528.85%
CTMXCytomX Therapeutics Inc24.82-1559.61%
XOMAOXOMA Royalty Corp25.34-1590.41%
HALOHalozyme Therapeutics Inc25.62-1606.81%
XOMAPXOMA Royalty Corp25.67-1609.54%
VRTXVertex Pharmaceuticals Inc27.99-1746.24%
RPRXRoyalty Pharma plc - Class A28.69-1786.98%
SLNOSoleno Therapeutics Inc29.02-1806.26%
ASNDAscendis Pharma A/S30.09-1869.19%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2329.43%
APLSApellis Pharmaceuticals Inc39.02-2394.66%
BMRNBiomarin Pharmaceutical Inc42.21-2582.28%
KRYSKrystal Biotech Inc45.34-2766.44%
ONCBeiGene Ltd69.54-4189.35%
PHARPharming Group N.V.75.03-4511.91%
TECHBio-Techne Corp101.96-6095.70%
VCELVericel Corp109.92-6563.97%
ALNYAlnylam Pharmaceuticals Inc117.96-7036.99%
GMABGenmab140.29-8349.86%
TLXTelix Pharmaceuticals Ltd162.15-9635.46%
CORTCorcept Therapeutics Inc212.86-12617.17%